Potential risk biomarkers found for schizophrenia resulting from cannabis use
A new study has analyzed and compared the fatty acids in the blood of individuals with schizophrenia, of those with cannabis use disorder and of those with both diagnoses, with the aim of shedding light on new biomarkers and improving the understanding of the biological relationship between the two disorders. The study also offers a powerful tool for identifying new biomarkers.
The War on Cannabis Takes a New Twist – Both Democrats and Republicans Step Up to Prevent Cannabis Legalization Cannabis Tourism in the US : The Top Destinations for Cannabis Enthusiasts and Fans
Comments are currently closed.